Hyperinducible expression of the interferon-gamma (IFN-γ) gene and its suppression in systemic lupus erythematosus (SLE)

Clinical and Experimental Immunology

Volumn 109, Issue 2, 1997, Pages 296-303

  Gerez, L ^a   Shkolnik, T ^b   Hirschmann, O ^a   Lorber, M ^c   Arad, G ^a   Kaempfer, R ^a  

^a HEBREW UNIVERSITY   (Israel)

^b Nahariya Hospital Israel   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Interferon gamma; mRNA; Suppression; Systemic lupus erythematosus

Indexed keywords

CYCLOHEXIMIDE; GAMMA INTERFERON; INTERLEUKIN 2; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030742301     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4471345.x     Document Type: Article

References (39)

1. Fauci AS, Moutsopoulos HM. Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in subjects with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 1981; 24:577-83.
2. Koffler D, Schur PH, Kunkel HG. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 1967; 126:607-24.
3. Cairns E, St. Germain J, Bell D. The in vitro production of anti-DNA antibody by cultured peripheral blood or tonsillar lymphoid cells from normal donors and SLE subjects. J Immunol 1985; 135:3839-44.
4. Jandl RC, George JL, Silberstein DS, Eaton RB, Schur PH. The effect of adherent cell-derived factors on immunoglobulin and anti-DNA synthesis in systemic lupus erythematosus. Clin Immunol Immunopathol 1987; 42:344-59.
5. + cells to support auto-antibody synthesis. Arthritis Rheum 1990; 33:1216-25.
6. 1 lupus-like nephritis with monoclonal antibodies to gamma interferon. J Exp Med 1987; 166:798-803.
7. Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis. Eur J Immunol 1995; 25:6-12.
8. Panitch HS, Hirsch RL, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon. Neurology 1987; 37:1097-102.
9. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988; 52:773-82.
10. Bermas BL, Petri M, Goldman D, Mittleman B, Miller MW, Stocks NJ, Via CS, Shearer GM. T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J Clin Immunol 1994; 14:169-77.
11. Funauchi M, Sugishima H, Minoda M, Horiuchi A. Serum level of interferon-gamma in autoimmune diseases. Tohoku J Exp Med 1991; 164:259-67.
12. Prud'homme GJ, Kono DH, Theofilopoulos AN. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice. Mol Immunol 1995; 32: 495-503.
13. Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, Galanaud P, Emilie D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994; 37:1647-55.
14. Llorente L, Zou W, Levy Y et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181:839-44.
15. Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JC. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995; 4:393-5.
16. Hagiwara E, Gourley MF, Lee S, Klinman DK. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 1996; 39:379-85.
17. Efrat S, Pilo S, Kaempfer R. Kinetics of induction and molecular size of mRNA species encoding human interleukin-2 and γ-interferon. Nature 1982; 297:236-9.
18. Efrat S, Kaempfer R. Control of biologically active interleukin-2 messenger RNA formation in induced human lymphocytes. Proc Natl Acad Sci USA 1984; 81:2601-5.
19. Lebendiker MA, Tal C, Sayar D, Pilo S, Eilon A, Banai Y, Kaempfer R. Superinduction of the human gene encoding immune interferon. EMBO J 1987; 6:585-9.
20. Ketzinel M, Efrat S, Sayar D, Gerez L, Tal C, Deutsch E, Arad G, Kaempfer R. Regulation of human interleukin-2 and interferon-γ gene expression by suppressor T lymphocytes. Scand J Immunol 1991; 33:593-605.
21. Arad G, Tal C, Ketzinel M, Nussinovich R, Deutsch E, Schlesinger M, Gerez L, Kaempfer R. Transient expression of human IL-2 and IFN-γ genes is regulated by interaction between distinct cell subsets. Cell Immunol 1995; 160:240-7.
22. Schwartz JL, Darr JC, Gaulden ME. Survival and PHA-stimulation of γ-irradiated human peripheral blood T lymphocyte subpopulations. Mutat Res 1983; 107:413-25.
23. Gullberg M, Larsson EL. Studies on induction and effector functions of concanavalin A-induced suppressor cells that limit TCGF production. J Immunol 1982; 128:746-50.
24. Jarrous N, Kaempfer R. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J Biol Chem 1994; 269:23141-9.
25. Gerez L, Arad G, Efrat S, Ketzinel M, Kaempfer R. Post-transcriptional regulation of human IL-2 gene expression at processing of precursor transcripts. J Biol Chem 1995; 270:15569-75.
26. Jarrous N, Osman F, Kaempfer R. 2-Aminopurine selectively inhibits splicing of tumor necrosis factor-α mRNA. Mol Cell Biol 1946; 16:2814-22.
27. Efrat S, Zelig S, Yagen B, Kaempfer R. Superinduction of human interleukin-2 messenger RNA by inhibitors of translation. Biochem Biophys Res Commun 1984; 123:842-8.
28. Gerez L, Madar L, Arad G et al. Aberrant regulation of interleukin-2 but not of interferon-γ gene expression in Down syndrome (trisomy 21). Clin Immunol Immunopathol 1991; 58:251-66.
29. Gerez L, Madar L, Shkolnik T et al. Regulation of interleukin-2 and interferon-γ gene expression in renal failure. Kidney Int 1991; 40:266-72.
30. Kaempfer R, Gerez L, Farbstein H, Madar L, Hirschman O, Nussinovich R, Shapiro A. Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression. J Clin Oncol 1996; 14:1778-86.
31. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
32. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective study. Arthritis Rheum 1991; 34:937-44.
33. Linker-Israeli M, Bakke AC, Quismorio Jr FP, Horwitz DA. Correction of interleukin-2 production in subjects with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest 1985; 75:762-8.
34. Arad G, Nussinovich R, Na'amad M, Kaempfer R. Dual control of human interleukin-2 and interferon-γ gene expression by histamine: activation and suppression. Cell Immunol 1996; 170:149-55.
35. Huang YO, Miescher P, Zubler R. The interleukin-2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. J Immunol 1986; 137:3515-20.
36. Funauchi M, Sugishima H, Minoda M, Horiuchi A. Effect of interferon-gamma on B lymphocytes of subjects with systemic lupus erythematosus. J Rheumatol 1991; 18:368-72.
37. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, Fujita K, Lipsky PE. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:96-104.
38. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146:3444-51.
39. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-22.